Nephroprotective potential of glucagon-like peptide-1 receptor agonists

by Minara S. Shamkhalova, Igor A. Sklyanik, Marina V. Shestakova
Published 2020

Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date

by Howell R, Wright AM, Clements JN
Published 2019

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice

by Lee J, Cho YK, Kim HS, Jung CH, Park JY, Lee WJ
Published 2019

Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment

by Li C, Wan L, Luo J, Jiang M, Wang K
Published 2021

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population

by Funch D, Mortimer K, Ziyadeh NJ, Seeger JD, Zhou L, Ng E, Ross D, Major-Pedersen A, Bosch-Traberg H, Gydesen H, Dore DD
Published 2021

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data

by Kugler AJ, Thiman ML
Published 2018

Is there an association between liraglutide use and female breast cancer in a real-world setting?

by Funch D, Mortimer K, Li L, Norman H, Major-Pedersen A, Olsen AH, Kaltoft MS, Dore DD
Published 2018

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes

by Gagik R. Galstyan, Evgeniya A. Karataeva, Ekaterina A. Yudovich
Published 2017

Mechanisms of neuroprotective action of incretin mimetics

by Timur Dmitrievich Vlasov, Anna Vladimirovna Simanenkova, Svetlana Vladimirovna Dora, Evgeniy Vladimirovich Shlyakhto
Published 2016

Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-compar...

by Orme ME, Nguyen H, Lu JY, Thomas SA
Published 2017

To Assess Liraglutide’s Therapeutic Effect in Patients with Type 2 Diabetes Mellitus Using Flash Glucose Monitoring System

by Yin J, Han M, Li L, Li Y, Liu Z, Yang J, Liu Y
Published 2021

Safety of Semaglutide

by Mark M. Smits, Daniël H. Van Raalte
Published 2021

Corrigendum: Safety of Semaglutide

by Mark M. Smits, Daniël H. Van Raalte
Published 2021

Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents

by Jelena Vekic, Aleksandra Zeljkovic, Aleksandra Stefanovic, Rosaria Vincenza Giglio, Marcello Ciaccio, Manfredi Rizzo
Published 2021

Adjunctive therapy for glucose control in patients with type 1 diabetes

by Harris K, Boland C, Meade L, Battise D
Published 2018

Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo

by Yanbin Dong, Jamie Carty, Nitsan Goldstein, Zhenyan He, Eunsang Hwang, Dominic Chau, Briana Wallace, Anita Kabahizi, Linh Lieu, Yunqian Peng, Yong Gao, Ling Hu, J. Nicholas Betley, Kevin W. Williams
Published 2021